Fennec Pharmaceuticals Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
18.79 M |
Public Float |
- |
Fennec Pharmaceuticals Inc. | |
Stock Exchange | Toronto Stock Exchange Prices |
EPS |
CAD0.74 |
Market Cap |
CAD105.95 M |
Shares Outstanding |
19.9 M |
Public Float |
- |
Address |
Research Triangle Park Durham North Carolina 27709 United States |
Employees | - |
Website | http://www.fennecpharma.com |
Updated | 07/08/2019 |
Fennec Pharmaceuticals, Inc. is a small stage biotechnology company, which engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC. |